drugset / Trial / NCT05868382
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The main purpose of the study is to evaluate the safety, reactogenicity, and the immunogenicity of mRNA-1010 vaccine candidate variations.
Timeline
- Start
- 2023-05-15
- Primary completion
- 2023-12-19
- Completion
- 2023-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quadrivalent influenza vaccine | Vaccine | — | Intramuscular |
| Subject | mRNA-1010.4 | Unknown | — | Intramuscular |
| Subject | mRNA-1010.6 | Unknown | — | Intramuscular |